The strength of the correlation was moderate at baseline except for the clinical outcome variables of CD4, HBG and weight and local measures of depression and stress which were small but increased during follow-up which is attributed to the effect of NAMWEZA intervention. This evidence concerns the gene CD4 and depressive symptom measurement.